Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended March 31, 2026 and ...

Banks' enthusiastic investments in artificial intelligence have not translated into equal levels of deployment. AI is now a ...